Publication | Closed Access

Alemtuzumab therapy for severe autoimmune hemolysis in a patient with B-cell chronic lymphocytic leukemia.

Hematological MalignancyImmunohematologyLymphoid NeoplasiaAutoimmune DiseaseHealth SciencesHematologyImmunologyAutoimmunityMedicineSevere Autoimmune HemolysisAlemtuzumab Therapy